ClinicalTrials.gg
RecruitingNCT07849517Updated Oct 28, 2026

Postoperative Delirium and Analgesia in Elderly Patients

An interventional study of adductor canal block and biFes block including bupivacain and Periarticular infiltration in Postoperative Delirium and Postoperative Pain, Acute, sponsored by Ankara City Hospital Bilkent. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by Ankara City Hospital Bilkent · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Oct 28, 2026Now RecruitingFirst site in Turkey (Türkiye)+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 92 studies in Emergence Delirium with a site in Turkey — 28 open to participants now, 32 under way, none of them phase 3. Emergence Delirium · Turkey.

Planned enrollment
Largest of 41
300 · median 80
Started
2026
with 27 others
No phase
35 of 92
13 open now
Primary completion
2027-05
later than 26 of 31 live
Registered
85th of 92
by date
Lead sponsor
4 of 92
Ankara City Hospital Bilkent

Among the 92 studies in Emergence Delirium with a site in Turkey, this one has the largest planned enrollment of the 41 interventional ones that give a count, is one of 28 that started in 2026, is one of 35 with no phase, reaches primary completion later than 26 of the 31 other live ones, and was the 85th registered.

Emergence Delirium

753 studies on the registry are indexed under Emergence Delirium; 261 are open to participants now.

Browse Emergence Delirium studies →

Open to participants now

28 of the 92 studies in Emergence Delirium with a site in Turkey are open now. Recruiting first, the newest first:

22 more — sign in →

All 28 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 141 Emergence Delirium studies recruiting now, 78 (55%) set no upper age limit and 43 (30%) stop at 75 or younger; 33 take children under 18; 24 take healthy volunteers.

This study: 60 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 92 studies in Emergence Delirium with a site in Turkey, or all of them as a file.
02

Study summary

This study aims to evaluate the effects of different postoperative analgesic approaches on postoperative delirium in elderly patients undergoing total knee arthroplasty.

Read the detailed description

This prospective randomized controlled study will evaluate the effects of two different postoperative analgesic approaches on postoperative delirium in elderly patients undergoing elective unilateral total knee arthroplasty under spinal anesthesia. Patients aged 60 years and older will be allocated into two groups according to the analgesic technique applied: Periarticular infiltration or adductor canal block combined with biceps femoris short head (BiFes) block. The primary outcome of the study is the incidence of postoperative delirium assessed using the 3D-CAM test at postoperative 12th, 24th, and 48th hours and on postoperative day 7. Secondary outcomes include postoperative pain scores (VAS/NRS), rescue opioid requirement, time to first mobilization, length of hospital stay, White's Fast-Track Score and patient satisfaction assessed with a Likert scale. The study aims to identify the optimal analgesic approach that provides effective pain control while minimizing neurocognitive complications and improving postoperative recovery in elderly patients undergoing total knee arthroplasty.

03

Conditions studied

  • Postoperative Delirium
  • Postoperative Pain, Acute

Keywords

  • Spinal anesthesia
  • Time to discharge
  • Rescue Opioid Requirement
  • Patient Satisfaction
  • Periarticular infiltration
  • Adductor canal block
  • BiFes block
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing elective unilateral total knee arthroplasty under spinal anesthesia
  • I-III
  • Age ≥60 years
  • (BMI) between 18-30 kg/m²
  • Preoperative fasting duration of approximately 8 hours

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate in the study or inability to provide written
  • (ASA) physical status IV or higher
  • Obese patients ( >30 kg/m²) or cachectic patients (BMI \<18 kg/m²)
  • Patients requiring general anesthesia or in whom spinal anesthesia could not be achieved
  • to spinal anesthesia
  • Emergency surgeries
  • Psychiatric or neurological disorders causing cognitive dysfunction (e.g., epilepsy, schizophrenia, dementia, Alzheimer's disease)
  • Use of psychotropic or opioid medications, or a history of alcohol abuse or withdrawal within the last 6 months
  • (MMSE) score ≤24
  • Stage III-IV hepatic encephalopathy
  • Severe impairments preventing cognitive assessment, such as blindness or severe hearing loss
  • Patients meeting delirium criteria according to baseline 3D-CAM assessment or unable to complete the test
  • History of cranio-cerebral surgery
  • Acute myocardial infarction within the previous 12 months before surgery
  • Requirement for postoperative intensive care unit admission
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
300 participants (estimated)

Study arms

  • Active comparator
    Adductor canal block and BiFes block

    Participants in this arm received postoperative analgesia via ultrasound-guided adductor canal block combined with BiFes block using 20 mL of 0.25% bupivacaine for each block following total knee arthroplasty under spinal anesthesia.

    Drug: adductor canal block and biFes block including bupivacain

  • Active comparator
    Periarticular infiltration

    Participants in this arm received postoperative analgesia with periarticular infiltration consisting of 100 mg bupivacaine, 40 mg methylprednisolone, 0.5 mg adrenaline and salin solution during total knee arthroplasty under spinal anesthesia.

    Drug: Periarticular infiltration

Interventions

  • Drugadductor canal block and biFes block including bupivacain

    Participants in this arm received postoperative analgesia via ultrasound-guided adductor canal block combined with BiFes block using 20 mL of 0.25% bupivacaine for each block following total knee arthroplasty under spinal anesthesia.

  • DrugPeriarticular infiltration

    Participants in this arm received postoperative analgesia with periarticular infiltration consisting of 100 mg bupivacaine, 40 mg methylprednisolone, 0.5 mg adrenaline and salin solution during total knee arthroplasty under spinal anesthesia.

06

What researchers measure

Primary outcomes

  1. Postoperative Delirium

    Postoperative delirium incidence assessed using the Diagnostic Interview for the Confusion Assessment Method (3D-CAM) in patients with a Mini-Mental State Examination score greater than 24.

    Time frame: 7 days postoperative

Secondary outcomes

  1. NRS ( Numeric Rating Scale )

    11-point numerical rating scale for pain (0='no pain' and 10='worst pain possible pain') were explained.

    Time frame: 48 hours postoperative

  2. Rescue Opioid Requirement

    The need for rescue opioid use and the administered dose will be recorded for each patient.

    Time frame: 48 hours postoperative

  3. Time to discharge

    Time to discharge will be defined as the duration from the end of surgery to hospital discharge, measured in hours.

    Time frame: up to 7 days

  4. Patient Satisfaction Score

    Patient satisfaction will assess prior to discharge using a Likert scale type (range, 1 to 10) verbally administered questionnaire.

    Time frame: 48 hours postoperative

  5. White's fast-track score

    Postoperative recovery will be assessed using the White's Fast-Track Score, which evaluates recovery based on activity level, hemodynamic stability, pain, nausea/vomiting, respiratory status, and consciousness level. ( range, 1 to 14 )

    Time frame: up to 7 days

  6. Time to first mobilization

    Time to first mobilization will be defined as the time elapsed between the end of surgery and the patient's first successful mobilization, measured in hours.

    Time frame: up to 7 days

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for May 2027, 7 months after the start.

Of 186 non-industry interventional studies with no phase under Emergence Delirium, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 7 months is below that.

Counting every sponsor, half of 186 studies reached it within 19 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2026
First posted
Sep 30, 2026
StartActual
Oct 1, 2026
Primary completionEst.
May 25, 2027
CompletionEst.
Jun 15, 2027
Last update
Oct 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 28, 2026
Sites
1 site added — first site in Turkey (Türkiye)
Show site
  • Ankara Bilkent City Hospital · Ankara, Turkey (Türkiye)
Oct 28, 2026
Registered
First appeared on the registry
Sep 30, 2026
Show all 2 updates
  1. Oct 28, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Turkey (Türkiye)
    Show site
    • Ankara Bilkent City Hospital · Ankara, Turkey (Türkiye)
    + 3 other changes: identifiers, verification date and date precision
  2. Sep 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07849517
Responsible party
Fatma Kavak Akelma (anesthesiology and reanimation professor, Ankara City Hospital Bilkent) — Principal investigator
First posted
Sep 30, 2026
Start date
Oct 1, 2026
Primary completion
May 25, 2027 (estimated)
Completion
Jun 15, 2027 (estimated)
Last update
Oct 28, 2026

Study contacts

FATMA KAVAK AKELMA
Contact
fatmakavakakelma@yahoo.com
03125962553
ALEYNA CALAP OCAK
Contact
aleynacalap@gmail.com
05452847074

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion